Each October, BCRF investigators are honored at the annual Symposium & Awards Luncheon in New York City. The event announces the Foundation’s grant investment for the coming year and recognizes BCRF investigators—many of whom will be in attendance—for their devotion to ending breast cancer and their trailblazing scientific inquiry.
Coming up on October 17, 2019, the program will begin with a symposium where an expert panel of BCRF investigators will discuss current breaking topics in breast cancer research, ranging from prevention and diagnosis to treatment and survivorship. The panel will be followed by a question and answer session with the audience.
This year’s featured speakers are Drs. Eric Winer, Dawn Hershman, Neil Iyengar, Judy Garber and Larry Norton. Dr. Winer is the 2019 recipient of the Jill Rose Award for Scientific Excellence.
Please follow the links below to learn more about each investigator.
2019 JILL ROSE AWARD FOR SCIENTIFIC EXCELLENCE Eric P. Winer, MD Professor, Medicine, Harvard Medical School Director, Breast Oncology Center, Dana-Farber Cancer Institute Physician Active Staff, Medicine, Brigham And Women’s Hospital, Dana-Farber Cancer Institute Boston, Massachusetts Member, BCRF Scientific Advisory Board Read about Dr. Winer and his research.
Dawn Hershman, MD, MS Professor of Medicine and Epidemiology Division of Medical Oncology Columbia University Medical Center New York, New York Conquer Cancer Foundation of ASCO Read about Dr. Hershman and her research.
Neil Iyengar, MD Assistant Member and Attending Physician, Breast Medicine Service, Memorial Sloan Kettering Cancer Center Associate Attending Physician, The Rockefeller University New York, New York Read about Dr. Iyengar and his research.
Judy E. Garber, MD, MPH Chief, Division of Cancer Genetics and Prevention Susan F. Smith Chair Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, Massachusetts BCRF Co-Scientific Director Read about Dr. Garber and her research.
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.
